Kazuki Nabeshima (K Nabeshima)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 11

Top Topics

Acute Lymphoblastic Leukemia

Top Venues

Pathology international

Cancer cytopathology

This page only lists publications with an associated author ORCID identifier.

Publications

Kazuki Nabeshima
Recommendation on the minimum time for follow-up in diagnosing mesothelioma in situ. Histopathology (2024)
Kazuki Nabeshima, Makoto Hamasaki, Yoshiaki Kinoshita, Shinji Matsumoto, Prakasit Sa-Ngiamwibool
Update of pathological diagnosis of pleural mesothelioma using genomic-based morphological techniques, for both histological and cytological investigations. Pathology international 72 (8) (2022)
Keiichiro Kitahama, Shinya Yoshiike, Kiyotaka Nagahama, Naoki Ninomiya, Takatsugu Okegawa, Hiroshi Fukuhara, Kazuki Nabeshima, Teruaki Oka, Junji Shibahara
Well-differentiated papillary mesothelial tumor presenting as an encysted hydrocele of the spermatic cord. Pathology international 72 (6) (2022)
Yoshiaki Kinoshita, Makoto Hamasaki, Shinji Matsumoto, Masayo Yoshimura, Ayuko Sato, Tohru Tsujimura, Toshiaki Kamei, Kunimitsu Kawahara, Akinori Iwasaki, Kazuki Nabeshima
Fluorescence in situ hybridization detection of chromosome 22 monosomy in pleural effusion cytology for the diagnosis of mesothelioma. Cancer cytopathology 129 (7) (2021)
Daisuke Mori, Shinichi Kido, Masatsugu Hiraki, Kenji Sumi, Norio Ureshino, Masanori Masuda, Kazuki Nabeshima, Michiaki Akashi
Peritoneal adenomatoid (microcystic) mesothelioma. Pathology international 70 (11) (2020)
Kouko Hidaka, Tetsushi Takeda, Yoshiaki Kinoshita, Kazuki Nabeshima, Sadafumi Tamiya, Yoshie Yoshikawa, Tohru Tsujimura
Development of mesothelioma in situ and its progression to invasive disease observed in a patient with uncontrolled pleural effusions for 15 years. Pathology international 70 (12) (2020)
Masayo Yoshimura, Makoto Hamasaki, Yoshiaki Kinoshita, Shinji Matsumoto, Ayuko Sato, Tohru Tsujimura, Akinori Iwasaki, Kazuki Nabeshima
Utility of highly expressed EZH2 in pleural effusion cytology for the diagnosis of mesothelioma. Pathology international 70 (10) (2020)
Masaru Miyazaki, Mikiko Aoki, Yasuko Okado, Kaori Koga, Makoto Hamasaki, Takashi Nakagawa, Toshifumi Sakata, Kazuki Nabeshima
Highly expressed tumoral emmprin and stromal CD73 predict a poor prognosis for external auditory canal carcinoma. Cancer science 111 (8) (2020)
Yoshiaki Kinoshita, Makoto Hamasaki, Shinji Matsumoto, Masayo Yoshimura, Ayuko Sato, Tohru Tsujimura, Toshiaki Kamei, Kunimitsu Kawahara, Kazuki Nabeshima
Genomic-based ancillary assays offer improved diagnostic yield of effusion cytology with potential challenges in malignant pleural mesothelioma. Pathology international 70 (9) (2020)
Shinji Matsumoto, Makoto Hamasaki, Yoshiaki Kinoshita, Toshiaki Kamei, Kunimitsu Kawahara, Kazuki Nabeshima
Morphological difference between pleural mesothelioma cells in effusion smears with either BAP1 loss or 9p21 homozygous deletion and reactive mesothelial cells without the gene alterations. Pathology international 69 (11) (2019)
M Aoki, K Koga, M Miyazaki, M Hamasaki, N Koshikawa, M Oyama, H Kozuka-Hata, M Seiki, B P Toole, Kazuki Nabeshima
CD73 complexes with emmprin to regulate MMP-2 production from co-cultured sarcoma cells and fibroblasts. BMC cancer 19 (1) (2019)